OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
Linheng Li, Roy A. Jensen
Cancer Research (2023) Vol. 83, Iss. 13, pp. 2096-2104
Open Access | Times Cited: 14
Linheng Li, Roy A. Jensen
Cancer Research (2023) Vol. 83, Iss. 13, pp. 2096-2104
Open Access | Times Cited: 14
Showing 14 citing articles:
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
The emerging role of oral microbiota in oral cancer initiation, progression and stemness
Partha Jyoti Saikia, Lekhika Pathak, Shirsajit Mitra, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Partha Jyoti Saikia, Lekhika Pathak, Shirsajit Mitra, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells
Yuan‐Tong Liu, Lei Chen, Shu‐Jin Li, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 11, pp. 1452-1466
Closed Access | Times Cited: 9
Yuan‐Tong Liu, Lei Chen, Shu‐Jin Li, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 11, pp. 1452-1466
Closed Access | Times Cited: 9
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Dormant Tumor Cells: Current Opportunities and Challenges in Clinical Practice
Emma Boydell, Maxime Borgeaud, Petros Tsantoulis
Onco (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Emma Boydell, Maxime Borgeaud, Petros Tsantoulis
Onco (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Role of liposomes in chemoimmunotherapy of Breast cancer
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access
Chronic High-Salt Diet Activates Tumor-Initiating Stem Cells Leading to Breast Cancer Proliferation
Lisa Tucker, Umer Ali, Roy Zent, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 912-912
Open Access | Times Cited: 3
Lisa Tucker, Umer Ali, Roy Zent, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 912-912
Open Access | Times Cited: 3
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements
Xifeng Fei, Jie Wu, Haiyan Tian, et al.
Cancer Biomarkers (2024) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 2
Xifeng Fei, Jie Wu, Haiyan Tian, et al.
Cancer Biomarkers (2024) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 2
NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer
Chrispus Ngule, Ruyi Shi, Xingcong Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Chrispus Ngule, Ruyi Shi, Xingcong Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
NAC1 Promotes Stemness and Regulates Myeloid-derived Cell Status in Triple-Negative Breast Cancer
Chrispus Ngule, Ruyi Shi, Xingcong Ren, et al.
Research Square (Research Square) (2024)
Open Access
Chrispus Ngule, Ruyi Shi, Xingcong Ren, et al.
Research Square (Research Square) (2024)
Open Access
UBE2T mediates the stemness properties of breast cancer cells through the mTOR signaling pathway
JIAWEI YIN, YONGSHENG WANG, Guangwei Wei, et al.
Biocell (2024) Vol. 48, Iss. 6, pp. 959-970
Open Access
JIAWEI YIN, YONGSHENG WANG, Guangwei Wei, et al.
Biocell (2024) Vol. 48, Iss. 6, pp. 959-970
Open Access
A future battle, small-molecule drugs for cancer stem cell targeted therapy
Junjie Ni, Xiaojing Du, Xuan Huang, et al.
Elsevier eBooks (2024), pp. 139-156
Closed Access
Junjie Ni, Xiaojing Du, Xuan Huang, et al.
Elsevier eBooks (2024), pp. 139-156
Closed Access
[Research Advances of RAD51AP1 in Tumor Progression and Drug Resistance].
Renwang Liu, Mingbiao Li, Zixuan Hu, et al.
PubMed (2023) Vol. 26, Iss. 9, pp. 701-708
Closed Access | Times Cited: 1
Renwang Liu, Mingbiao Li, Zixuan Hu, et al.
PubMed (2023) Vol. 26, Iss. 9, pp. 701-708
Closed Access | Times Cited: 1
